Park Dental Partners (PARK) reported Q1 adjusted earnings late Wednesday of $0.44 per diluted share, down from $1.14 a year earlier.
Two analysts surveyed by FactSet expected $0.20.
Revenue in the three months ended March 31 rose to $62.7 million from $59 million a year earlier.
Two analysts polled by FactSet expected $61 million.
The company expects full-year revenue of $254 million to $258 million. Two analysts project $256.6 million.
Park Dental shares rose 5.4% in after-hours trading.
Aeluma (ALMU) reported Wednesday that fiscal Q3 swung to loss of $0.10 per diluted share, compared with earnings of $0.11 a year earlier.FactSet data was not available.Revenue for the quarter ended March 31 was $1.2 million, down from $1.3 million a year ago.Two analysts surveyed by FactSet expected $1.4 million.For fiscal 2026, the company narrowed revenue guidance to between $4.2 million and $4.6 million from a prior range of $4.0 million to $6.0 million. Two analysts expect $5.4 million.
PDF Solutions (PDFS) said late Wednesday it launched a public offering of over 3.8 million common shares.More than 3.3 million shares will be sold by existing stakeholder Advantest America while 500,000 shares will be offered by the company, according to a statement.The company will grant the underwriters a 30-day overallotment option to buy up to an additional 571,038 shares, the company said.Shares of the company were down nearly 10% during after-hours trading.
Prestige Consumer Healthcare (PBH) reported fiscal Q4 adjusted earnings late Wednesday of $1.23 per diluted share, down from $1.32 a year earlier.Analysts surveyed by FactSet expected $1.39.Revenue for the quarter ended March 31 was $281.6 million, down from $296.5 million a year earlier.Analysts polled by FactSet expected $293.6 million.The company expects fiscal 2027 adjusted EPS of $4.42 to $4.51 on revenue of $1.10 billion to $1.12 billion. Analysts expect $4.79 and $1.16 billion, respectively.Also, the company said it agreed to acquire Australia-based LaCorium Health, a therapeutic skin care provider designed to treat individual skin ailments, for about $150 million in cash. The transaction, subject to customary conditions, is expected to close in Q2, it added.